• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 3'-N-苯磺酰基多西他赛类似物的合成及抗 HBV 活性。

Synthesis and anti-HBV activity of novel 3'-N-phenylsulfonyl docetaxel analogs.

机构信息

Department of Natural Products Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China.

出版信息

Molecules. 2013 Aug 22;18(9):10189-212. doi: 10.3390/molecules180910189.

DOI:10.3390/molecules180910189
PMID:23973993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6270178/
Abstract

Nine new 3'-N-phenylsulfonyl docetaxel analogs were synthesized in good yields from the key intermediate N-phenylsulfonyl oxazolidine via a six-step route. These analogs were tested for anti-hepatitis B virus (HBV) activity in vitro. Compounds 3e, 3g and 3j showed more potent inhibitory activity against HBeAg secretion than the positive control lamivudine. Further extensive SAR and mechanistic studies will be reported in due course.

摘要

从关键中间体 N-苯磺酰基恶唑烷通过六步反应路线,以良好的收率合成了 9 种新型 3'-N-苯磺酰基多西他赛类似物。这些类似物在体外进行了抗乙型肝炎病毒(HBV)活性测试。化合物 3e、3g 和 3j 对 HBeAg 分泌的抑制活性强于阳性对照拉米夫定。进一步的广泛 SAR 和机制研究将在适当的时候报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/68fc0f3e991b/molecules-18-10189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/d6e518c9d45a/molecules-18-10189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/f8b2927de66c/molecules-18-10189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/41ae8d262475/molecules-18-10189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/68fc0f3e991b/molecules-18-10189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/d6e518c9d45a/molecules-18-10189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/f8b2927de66c/molecules-18-10189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/41ae8d262475/molecules-18-10189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d52/6270178/68fc0f3e991b/molecules-18-10189-g004.jpg

相似文献

1
Synthesis and anti-HBV activity of novel 3'-N-phenylsulfonyl docetaxel analogs.新型 3'-N-苯磺酰基多西他赛类似物的合成及抗 HBV 活性。
Molecules. 2013 Aug 22;18(9):10189-212. doi: 10.3390/molecules180910189.
2
Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.尾叶素类似物作为强效乙型肝炎病毒抑制剂的设计、合成及生物学评价
Med Chem. 2015;11(2):165-79. doi: 10.2174/1573406410666140902111326.
3
Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.新型抗乙型肝炎病毒药物白头翁苷衍生物的合成、构效关系及生物评价。
Bioorg Med Chem. 2012 May 1;20(9):2877-88. doi: 10.1016/j.bmc.2012.03.023. Epub 2012 Mar 16.
4
Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs.新型异黄酮类似物的抗乙型肝炎病毒和抗癌活性。
Eur J Med Chem. 2013 Apr;62:158-67. doi: 10.1016/j.ejmech.2012.09.017. Epub 2012 Sep 20.
5
Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.丹皮酚衍生物作为潜在抗乙肝病毒药物的设计、合成及生物活性评价
Eur J Med Chem. 2015 Jan 27;90:428-35. doi: 10.1016/j.ejmech.2014.11.050. Epub 2014 Nov 26.
6
Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.新型N(4)-取代的2'-脱氧-2'-氟-4'-叠氮胞苷衍生物作为强效抗乙肝病毒药物的设计、合成及生物学评价
Eur J Med Chem. 2015 Aug 28;101:103-10. doi: 10.1016/j.ejmech.2015.06.030. Epub 2015 Jun 22.
7
Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.作为非核苷类乙型肝炎病毒抑制剂的吡唑衍生物的设计、合成与评价
Eur J Med Chem. 2016 Nov 10;123:202-210. doi: 10.1016/j.ejmech.2016.07.048. Epub 2016 Jul 25.
8
Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.合成 hemslecin A 衍生物:一类新型乙型肝炎病毒抑制剂。
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1201-5. doi: 10.1016/j.bmcl.2013.01.024. Epub 2013 Jan 16.
9
Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.苯丙素衍生物作为强效抗乙型肝炎病毒药物的设计、合成、生物学评价及分子对接研究
Eur J Med Chem. 2015 May 5;95:473-82. doi: 10.1016/j.ejmech.2015.03.056. Epub 2015 Mar 27.
10
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.新型1,2,3-三唑-2'-脱氧-2'-氟-4'-叠氮核苷衍生物作为强效抗乙肝病毒药物的设计、合成及生物学评价
Eur J Med Chem. 2018 Jan 1;143:137-149. doi: 10.1016/j.ejmech.2017.11.028. Epub 2017 Nov 10.

本文引用的文献

1
Synthesis, cytotoxicity, metabolic stability and pharmacokinetic evaluation of fluorinated docetaxel analogs.氟代多西他赛类似物的合成、细胞毒性、代谢稳定性和药代动力学评价。
Eur J Med Chem. 2011 May;46(5):1743-8. doi: 10.1016/j.ejmech.2011.02.027. Epub 2011 Feb 22.
2
Drug targets in hepatitis B virus infection.乙型肝炎病毒感染中的药物靶点
Infect Disord Drug Targets. 2009 Apr;9(2):105-16. doi: 10.2174/187152609787847677.
3
Emerging antiviral drugs.新型抗病毒药物。
Expert Opin Emerg Drugs. 2008 Sep;13(3):393-416. doi: 10.1517/14728214.13.3.393.
4
Synthesis and biological evaluation of novel 3'-N-tert-butylsulfonyl analogues of docetaxel.
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4783-5. doi: 10.1016/j.bmcl.2008.07.101. Epub 2008 Jul 29.
5
Design, synthesis and biological evaluation of novel fluorinated docetaxel analogues.新型氟化多西他赛类似物的设计、合成及生物学评价
Eur J Med Chem. 2009 Feb;44(2):482-91. doi: 10.1016/j.ejmech.2008.04.004. Epub 2008 Apr 27.
6
Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.慢性乙型肝炎病毒感染的抗病毒治疗:过去、现在与未来
Rev Med Virol. 2008 Jan-Feb;18(1):19-34. doi: 10.1002/rmv.554.
7
Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B.慢性乙型肝炎的药物靶点与耐药分子机制
Gastroenterology. 2007 Apr;132(4):1574-85. doi: 10.1053/j.gastro.2007.02.039.
8
HBV drug resistance: mechanisms, detection and interpretation.乙肝病毒耐药性:机制、检测与解读
J Hepatol. 2006 Mar;44(3):593-606. doi: 10.1016/j.jhep.2006.01.001. Epub 2006 Jan 19.
9
Hepatitis B virus infection--natural history and clinical consequences.乙型肝炎病毒感染——自然史与临床后果
N Engl J Med. 2004 Mar 11;350(11):1118-29. doi: 10.1056/NEJMra031087.
10
Antiviral sulfonamide derivatives.抗病毒磺酰胺衍生物
Mini Rev Med Chem. 2004 Feb;4(2):189-200. doi: 10.2174/1389557043487402.